FDA — authorised 27 September 1991
- Marketing authorisation holder: CLINIGEN HLTHCARE
- Status: approved
🇺🇸 Foscavir in United States
FDA authorised Foscavir on 27 September 1991
Marketing authorisations
FDA — authorised 27 September 1991
- Application: NDA020068
- Marketing authorisation holder: CLINIGEN HLTHCARE
- Local brand name: FOSCAVIR
- Indication: SOLUTION — INTRAVENOUS
- Status: approved
Foscavir in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is Foscavir approved in United States?
Yes. FDA authorised it on 27 September 1991; FDA authorised it on 27 September 1991.
Who is the marketing authorisation holder for Foscavir in United States?
CLINIGEN HLTHCARE holds the US marketing authorisation.